Officials Cast Doubt on a Dementia Drug, but Human Trials Continuenews2024-10-02T19:41:40+00:00October 2nd, 2024|The New York Times|
F.D.A. Approves a New Antipsychotic Drugnews2024-09-27T14:36:45+00:00September 27th, 2024|The New York Times|
Qué es la rapamicina y por qué se piensa que sirve para mantenerse jovennews2024-09-24T21:30:27+00:00September 24th, 2024|The New York Times|
Rapamycin and Anti-Aging: What to Knownews2024-09-24T15:26:30+00:00September 24th, 2024|The New York Times|
El ‘médico rural’ que transformó nuestra manera de ver la demencianews2024-09-14T09:03:22+00:00September 14th, 2024|The New York Times|
Francisco Lopera, the ‘Country Doctor’ Who Upended Our Understanding of Dementianews2024-09-11T14:07:34+00:00September 11th, 2024|The New York Times|
An Obesity Drug Prevents Covid Deaths, Study Suggestsnews2024-08-30T16:19:32+00:00August 30th, 2024|The New York Times|
FDA Declines to Approve MDMA Therapy, and Seeks Further Studynews2024-08-10T11:56:53+00:00August 10th, 2024|The New York Times|
Veterans and Lawmakers Lobby for Approval of MDMA Therapynews2024-08-08T22:01:37+00:00August 8th, 2024|The New York Times|
Executives Depart Cassava, Maker of Disputed Alzheimer’s Drugnews2024-07-18T22:21:49+00:00July 18th, 2024|The New York Times|
